Anke Salmen, Robert Hoepner, Vinzenz Fleischer, Milena Heldt, Barbara Gisevius, Jeremias Motte, Klemens Ruprecht, Ruth Schneider, Anna Lena Fisse, Thomas Grüter, Carsten Lukas, Achim Berthele, Katrin Giglhuber, Martina Flaskamp, Mark Mühlau, Jan Kirschke, Stefan Bittner, Sergiu Groppa, Felix Lüssi, Antonios Bayas, Sven Meuth, Cristoph Heesen, Corinna Trebst, Brigitte Wildemann, Florian Then Bergh, Gisela Antony, Tania Kümpfel, Friedemann Paul, Sandra Nischwitz, Hayrettin Tumani, Uwe Zettl, Bernhard Hemmer, Heinz Wiendl, Frauke Zipp, Ralf Gold
- Background: Depression has a major impact on the disease burden of multiple sclerosis (MS). Analyses of overlapping MS and depression risk factors [smoking, vitamin D (25-OH-VD) and Epstein-Barr virus (EBV) infection] and sex, age, disease characteristics and neuroimaging features associated with depressive symptoms in early MS are scarce.
Objectives: To assess an association of MS risk factors with depressive symptoms within the German NationMS cohort.
Design: Cross-sectional analysis within a multicenter observational study.
Methods: Baseline data of n = 781 adults with newly diagnosed clinically isolated syndrome or relapsing-remitting MS qualified for analysis. Global and region-specific magnetic resonance imaging (MRI)-volumetry parameters were available for n = 327 patients. Association of demographic factors, MS characteristics and risk factors [sex, age, smoking, disease course, presence of current relapse, expanded disability status scale (EDSS) score, fatigueBackground: Depression has a major impact on the disease burden of multiple sclerosis (MS). Analyses of overlapping MS and depression risk factors [smoking, vitamin D (25-OH-VD) and Epstein-Barr virus (EBV) infection] and sex, age, disease characteristics and neuroimaging features associated with depressive symptoms in early MS are scarce.
Objectives: To assess an association of MS risk factors with depressive symptoms within the German NationMS cohort.
Design: Cross-sectional analysis within a multicenter observational study.
Methods: Baseline data of n = 781 adults with newly diagnosed clinically isolated syndrome or relapsing-remitting MS qualified for analysis. Global and region-specific magnetic resonance imaging (MRI)-volumetry parameters were available for n = 327 patients. Association of demographic factors, MS characteristics and risk factors [sex, age, smoking, disease course, presence of current relapse, expanded disability status scale (EDSS) score, fatigue (fatigue scale motor cognition), 25-OH-VD serum concentration, EBV nuclear antigen-1 IgG (EBNA1-IgG) serum levels] and depressive symptoms (Beck Depression Inventory-II, BDI-II) was tested as a primary outcome by multivariable linear regression. Non-parametric correlation and group comparison were performed for associations of MRI parameters and depressive symptoms.
Results: Mean age was 34.3 years (95% confidence interval: 33.6-35.0). The female-to-male ratio was 2.3:1. At least minimal depressive symptoms (BDI-II > 8) were present in n = 256 (32.8%), 25-OH-VD deficiency (<20 ng/ml) in n = 398 (51.0%), n = 246 (31.5%) participants were smokers. Presence of current relapse [coefficient (c) = 1.48, p = 0.016], more severe fatigue (c = 0.26, p < 0.0001), lower 25-OH-VD (c = -0.03, p = 0.034) and smoking (c = 0.35, p = 0.008) were associated with higher BDI-II scores. Sex, age, disease course, EDSS, month of visit, EBNA1-IgG levels and brain volumes at baseline were not.
Conclusion: Depressive symptoms need to be assessed in early MS. Patients during relapse seem especially vulnerable to depressive symptoms. Contributing factors such as fatigue, vitamin D deficiency and smoking, could specifically be targeted in future interventions and should be investigated in prospective studies.…
MetadatenAuthor: | Anke Salmen, Robert Hoepner, Vinzenz Fleischer, Milena Heldt, Barbara Gisevius, Jeremias Motte, Klemens Ruprecht, Ruth Schneider, Anna Lena Fisse, Thomas Grüter, Carsten Lukas, Achim Berthele, Katrin Giglhuber, Martina Flaskamp, Mark Mühlau, Jan Kirschke, Stefan Bittner, Sergiu Groppa, Felix Lüssi, Antonios BayasORCiDGND, Sven Meuth, Cristoph Heesen, Corinna Trebst, Brigitte Wildemann, Florian Then Bergh, Gisela Antony, Tania Kümpfel, Friedemann Paul, Sandra Nischwitz, Hayrettin Tumani, Uwe Zettl, Bernhard Hemmer, Heinz Wiendl, Frauke Zipp, Ralf Gold |
---|
Frontdoor URL | https://opus.bibliothek.uni-augsburg.de/opus4/108322 |
---|
ISSN: | 1756-2864OPAC |
---|
Parent Title (English): | Therapeutic Advances in Neurological Disorders |
---|
Publisher: | SAGE Publications |
---|
Type: | Article |
---|
Language: | English |
---|
Date of first Publication: | 2023/09/08 |
---|
Publishing Institution: | Universität Augsburg |
---|
Release Date: | 2023/10/13 |
---|
Tag: | Neurology (clinical); Neurology; Pharmacology |
---|
Volume: | 16 |
---|
First Page: | 1 |
---|
Last Page: | 16 |
---|
DOI: | https://doi.org/10.1177/17562864231197309 |
---|
Institutes: | Medizinische Fakultät |
---|
| Medizinische Fakultät / Universitätsklinikum |
---|
| Medizinische Fakultät / Lehrstuhl für Neurologie |
---|
Dewey Decimal Classification: | 6 Technik, Medizin, angewandte Wissenschaften / 61 Medizin und Gesundheit / 610 Medizin und Gesundheit |
---|
Latest Publications (not yet published in print): | Aktuelle Publikationen (noch nicht gedruckt erschienen) |
---|
Licence (German): | CC-BY-NC 4.0: Creative Commons: Namensnennung - Nicht kommerziell (mit Print on Demand) |
---|